Early research (Phase 1)Looking for participantsNCT07247266
What this trial is testing
Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS)
Who this might be right for
Cryopyrin-associated Periodic Syndromes (CAPS)
Akros Pharma Inc. 5